Table 4

Percentage of patients receiving treatment intensification (among patients with elevated risk factor values) by patient race/ethnicity

African American patientsHispanic patientsWhite patients
UnadjustedAdjustedOR (95% CI)UnadjustedAdjustedOR (95% CI)UnadjustedAdjustedOR (95% CI)
A1C <8%7673 ± 1.2*0.82 (0.71–0.94)7775 ± 1.10.92 (0.80–1.05)7877Ref
LDL cholesterol <100 mg/dl4444 ± 1.00.96 (0.87–1.04)4747 ± 1.1†1.1 (1.0–1.2)4345Ref
SBP <140 mmHg7078 ± 1.3‡1.47 (1.28–1.68)7774 ± 1.51.1 (0.98–1.33)7871Ref
  • Data are %, % ± SEM, and ORs (95% CI). Physician random effect probit and logistic regression models were adjusted for patient age, sex, preferred language, number of comorbidities, number of primary care visits in 2005, Medicare status, number of medication classes taken for condition, laboratory values, pill burden, geocoded education and income, physician age, sex, race/ethnicity, language, panel size, and number of diabetic patients in panel. White patients are the referent (Ref) group.

  • *P < 0.01;

  • P < 0.05;

  • P < 0.001.